Halozyme Therapeutics, Inc. (HALO)
110.42
+0.58
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
110.75
+0.33
(+0.30%)
After-Hours: 20:00
Halozyme Therapeutics 30-Day Average Daily Volume : 2.288M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.288M |
| October 08, 2026 | 2.272M |
| October 07, 2026 | 2.246M |
| October 06, 2026 | 2.227M |
| October 05, 2026 | 2.237M |
| October 02, 2026 | 2.214M |
| October 01, 2026 | 2.180M |
| September 30, 2026 | 2.187M |
| September 29, 2026 | 2.135M |
| September 28, 2026 | 2.112M |
| September 25, 2026 | 2.093M |
| September 24, 2026 | 2.094M |
| September 23, 2026 | 2.110M |
| September 22, 2026 | 2.114M |
| September 21, 2026 | 2.141M |
| September 18, 2026 | 2.301M |
| September 17, 2026 | 2.052M |
| September 16, 2026 | 2.028M |
| September 15, 2026 | 2.023M |
| September 14, 2026 | 2.034M |
| September 11, 2026 | 2.055M |
| September 10, 2026 | 2.098M |
| September 09, 2026 | 2.103M |
| September 08, 2026 | 2.133M |
| September 04, 2026 | 2.126M |
| Date | Value |
|---|---|
| September 03, 2026 | 2.148M |
| September 02, 2026 | 2.143M |
| September 01, 2026 | 2.136M |
| August 31, 2026 | 2.143M |
| August 28, 2026 | 2.152M |
| August 27, 2026 | 2.146M |
| August 26, 2026 | 2.165M |
| August 25, 2026 | 2.153M |
| August 24, 2026 | 2.159M |
| August 21, 2026 | 2.150M |
| August 20, 2026 | 2.161M |
| August 19, 2026 | 2.168M |
| August 18, 2026 | 2.166M |
| August 17, 2026 | 2.169M |
| August 14, 2026 | 2.179M |
| August 13, 2026 | 2.176M |
| August 12, 2026 | 2.169M |
| August 11, 2026 | 2.112M |
| August 10, 2026 | 2.092M |
| August 07, 2026 | 2.023M |
| August 06, 2026 | 1.815M |
| August 05, 2026 | 1.790M |
| August 04, 2026 | 1.838M |
| August 03, 2026 | 1.821M |
| July 31, 2026 | 1.897M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AVITA Medical, Inc. | 307728.7 |
| Iovance Biotherapeutics, Inc. | 16.65M |
| Merck & Co., Inc. | 9.427M |
| Incyte Corp. | 1.609M |
| Agenus, Inc. | 1.080M |